These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7737594)

  • 1. [Effects of Onpi-to (TJ-8117) on mesangial injury induced by anti Thy-1 antibody].
    Hattori T; Shindo S; Hisada T; Fujitsuka N; Hibino T; Terazono Y; Maruno M
    Nihon Yakurigaku Zasshi; 1995 Feb; 105(2):63-75. PubMed ID: 7737594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive effects of Sairei-to on mesangial proliferation in a rat model of glomerulonephritis.
    Liu N; Makino T; Honda G; Muso E; Kita T; Ono T
    Clin Exp Nephrol; 2004 Sep; 8(3):216-22. PubMed ID: 15480898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive mechanisms of Sairei-to on mesangial matrix expansion in rat mesangioproliferative glomerulonephritis.
    Ono T; Liu N; Makino T; Nogaki F; Muso E; Honda G; Kita T
    Nephron Exp Nephrol; 2005; 100(3):e132-42. PubMed ID: 15824516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shenhua Tablet inhibits mesangial cell proliferation in rats with chronic anti-Thy-1 nephritis.
    Geng W; Wei R; Liu S; Tang L; Zhu H; Chen P; Wu J; Zhang X; Zhu F; Yin Z; Chen X
    Biol Res; 2016 Mar; 49():17. PubMed ID: 26969153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental treatment of rhubarb on mesangio-proliferative glomerulonephritis in rats].
    Wei J; Ni L; Yao J
    Zhonghua Nei Ke Za Zhi; 1997; 36(2):87-9. PubMed ID: 9812565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
    Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
    Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
    Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerulosclerosis in the rat induced by repeated immune-mediated mesangial cell injury.
    Iida H; Izumino K; Asaka M; Entani C; Takata M; Johnson RJ
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):905-12. PubMed ID: 7902884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-10 in rat mesangioproliferative glomerulonephritis.
    Robertson TE; Nikolic-Paterson DJ; Tesch GH; Foti RA; Atkins RC; Chadban SJ
    Nephrology (Carlton); 2003 Feb; 8(1):33-41. PubMed ID: 15012748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
    Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis.
    Floege J; Eng E; Lindner V; Alpers CE; Young BA; Reidy MA; Johnson RJ
    J Clin Invest; 1992 Dec; 90(6):2362-9. PubMed ID: 1361494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of sairei-to (TJ-114) on the expression of adhesion molecule in anti-GBM nephritic rats].
    Hattori T; Shindo S
    Nihon Jinzo Gakkai Shi; 1995 Jul; 37(7):373-83. PubMed ID: 7543621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of onpi-to (TJ-8117) and (-)epicatechin-3-O-gallate on the proliferating changes in glomeruli of 5/6 nephrectomized rats].
    Fujitsuka N; Kurogi A; Hattori T; Shindo S
    Nihon Jinzo Gakkai Shi; 1997 Oct; 39(7):693-700. PubMed ID: 9396236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin (AM) and receptor-activity-modifying proteins in glomeruli with Thy.1 glomerulonephritis.
    Matsumoto M; Fujimoto S; Iwatsubo S; Sato Y; Hara S; Kitamura K; Eto T
    Clin Exp Nephrol; 2004 Dec; 8(4):316-21. PubMed ID: 15619030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of KD3-671, an angiotensin II type 1 receptor antagonist, on anti-thy-1 nephritis in rats.
    Nagamatsu T; Oka T; Nagao T; Suzuki Y
    Biol Pharm Bull; 2003 Jun; 26(6):808-12. PubMed ID: 12808291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranilast ameliorates experimental mesangial proliferative glomerulonephritis.
    Tokuyama H; Kelly DJ; Cox A; Zhang Y; Thai K; Nikolic-Paterson DJ; Gilbert RE
    Nephron Exp Nephrol; 2008; 109(1):e1-7. PubMed ID: 18480612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Colquhoumia root on the expression of transforming growth factor-beta in mesangial proliferation glomerulonephritis model.
    Zeng H; Chang W
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(4):412-5. PubMed ID: 16196290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative nephritogenicity of two monoclonal antibodies that recognize different epitopes of rat Thy-1.1 molecule.
    Nakayama H; Oite T; Kawachi H; Morioka T; Kobayashi H; Orikasa M; Arakawa M; Shimizu F
    Nephron; 1998; 78(4):453-63. PubMed ID: 9578072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplementation of heterologous complement induces anti-Thy-1.1 nephritis in the Mongolian gerbil (Meriones unguiculatus).
    Shichinohe K; Shimizu-Suganuma M; Ghazizadeh M; Ishizaki M
    J Vet Med Sci; 2002 Jun; 64(6):463-7. PubMed ID: 12130828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.